CAFIASPIRINA Trademark

Trademark Overview


On Thursday, September 14, 2023, a trademark application was filed for CAFIASPIRINA with the United States Patent and Trademark Office. The USPTO has given the CAFIASPIRINA trademark a serial number of 98179263. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, October 29, 2024. This trademark is owned by IPS Trust. The CAFIASPIRINA trademark is filed in the Pharmaceutical Products category with the following description:

Pain relief medication
cafiaspirina

General Information


Serial Number98179263
Word MarkCAFIASPIRINA
Filing DateThursday, September 14, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateTuesday, October 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements


Goods and ServicesPain relief medication

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 14, 2023
Primary Code005
First Use Anywhere DateTuesday, August 27, 2024
First Use In Commerce DateTuesday, August 27, 2024

Trademark Owner History


Party NameIPS Trust
Party Type20 - Owner at Publication
Legal Entity Type17 - Trust
AddressArlington, VA 22201

Party NameIPS Trust
Party Type10 - Original Applicant
Legal Entity Type17 - Trust
AddressArlington, VA 22201

Trademark Events


Event DateEvent Description
Thursday, September 14, 2023NEW APPLICATION ENTERED
Tuesday, November 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 5, 2023ASSIGNED TO EXAMINER
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 27, 2024USE AMENDMENT FILED
Tuesday, August 27, 2024TEAS STATEMENT OF USE RECEIVED
Monday, October 28, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 29, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 29, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, October 28, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords


cafiaspirina medication relief pain